Literature DB >> 24129917

[Glaucoma and dry eye. Current concepts and future perspectives].

P Steven1, C Cursiefen.   

Abstract

PURPOSE: Current concepts and future perspectives for therapy and prevention of dry eye in glaucoma patients are described.
METHODS: Own clinical and experimental findings and PubMed based literature search (keywords: glaucoma and dry eye).
RESULTS: Ocular surface disease is the main long-term complication of glaucoma therapy. Prevention of ocular surface inflammation by preservative-free antiglaucoma eye drops and concurrent dry eye therapy are important
CONCLUSIONS: It is mandatory to treat dry eye prior to and during glaucoma therapy. Preservative-free glaucoma medication can help to ameliorate the problem.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24129917     DOI: 10.1007/s00347-012-2675-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  27 in total

Review 1.  [Anti-inflammatory treatment in dry eye disease].

Authors:  P Steven; C Cursiefen
Journal:  Klin Monbl Augenheilkd       Date:  2012-05-16       Impact factor: 0.700

2.  [International Dry Eye Workshop (DEWS). Update of the disease].

Authors:  R Herrero-Vanrell; A Peral
Journal:  Arch Soc Esp Oftalmol       Date:  2007-12

3.  Amniotic membrane-covered bio-onlays for treatment of ocular surface disease.

Authors:  C Cursiefen; C Rummelt; M W Beckmann; F E Kruse
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

Review 4.  [Current treatment for dry eye syndrome].

Authors:  C Cursiefen; C Jacobi; T Dietrich; F E Kruse
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

5.  Non-contact meibography: keep it simple but effective.

Authors:  H Pult; B H Riede-Pult
Journal:  Cont Lens Anterior Eye       Date:  2011-08-31       Impact factor: 3.077

6.  Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease.

Authors:  John D Sheppard; Stephen V Scoper; Sandeep Samudre
Journal:  J Ocul Pharmacol Ther       Date:  2010-12-06       Impact factor: 2.671

Review 7.  [Inflammation of the eye in systemic inflammatory disorders: keratitis].

Authors:  B Bachmann; C Jacobi; C Cursiefen
Journal:  Klin Monbl Augenheilkd       Date:  2011-04-29       Impact factor: 0.700

8.  Relationship between in vitro toxicity of benzalkonium chloride (BAC) and preservative-induced dry eye.

Authors:  M De Saint Jean; C Debbasch; F Brignole; J M Warnet; C Baudouin
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

9.  [Influence of dry eye syndrome on glaucoma diagnostic procedures].

Authors:  F Rüfer; C Erb
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

10.  Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.

Authors:  Felix Bock; Jasmine Onderka; Tina Dietrich; Björn Bachmann; Friedrich E Kruse; Matthias Paschke; Grit Zahn; Claus Cursiefen
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.